UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase Ib/II single-arm trial evaluating the combination of everolimus, lapatinib and capecitabine for the treatment of HER2-positive breast cancer with brain metastases (TRIO-US B-09)

Therapeutic advances in medical oncology, 2018-01, Vol.10, p.1758835918807339

2018

Volltextzugriff (PDF)

Trastuzumab emtansine plus atezolizumab versus trastuzumab emtansine plus placebo in previously treated, HER2-positive advanced breast cancer (KATE2): a phase 2, multicentre, randomised, double-blind trial

The lancet oncology, 2020-10, Vol.21 (10), p.1283-1295

2020

Volltextzugriff (PDF)

Defining the Survival Benchmark for Breast Cancer Patients with Systemic Relapse

Breast Cancer: Basic and Clinical Research, 2015-01, Vol.2015 (2015), p.9-17

2015

Volltextzugriff (PDF)

Final results of the double-blind placebo-controlled randomized phase 2 LOTUS trial of first-line ipatasertib plus paclitaxel for inoperable locally advanced/metastatic triple-negative breast cancer

Breast cancer research and treatment, 2021-09, Vol.189 (2), p.377-386

2021

Volltextzugriff (PDF)

Abstract PS5-06: Prospective testing for PIK3CA/AKT1/PTEN alterations in tumor tissue from 1440 patients with advanced hormone receptor-positive HER2-negative breast cancer (HR+/HER2- BC) or triple-negative breast cancer (TNBC) screened for the IPATunity130 randomized phase 3 trial

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS5-06-PS5-06

2021

Volltextzugriff (PDF)

Abstract PD14-03: Molecular mechanism of ipatasertib (IPAT) and its combination with atezolizumab (atezo) in patients (pts) with locally advanced/metastatic triple-negative breast cancer (aTNBC)

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PD14-03-PD14-03

2021

Volltextzugriff (PDF)

Abstract GS3-04: Double-blind placebo (PBO)-controlled randomized phase III trial evaluating first-line ipatasertib (IPAT) combined with paclitaxel (PAC) for PIK3CA/AKT1/PTEN -altered locally advanced unresectable or metastatic triple-negative breast cancer (aTNBC): primary results from IPATunity130 Cohort A

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.GS3-04-GS3-04

2021

Volltextzugriff (PDF)

Real-world (RW) characteristics, treatment (tx) patterns, and overall survival (OS) in US patients (pts) with metastatic breast cancer (mBC) and CNS metastases (CNS mets)

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.1037-1037

2018

Volltextzugriff (PDF)

Abstract P4-10-23: Expression of PD-L1 is independent of PIK3CA/AKT1/PTEN alterations in triple-negative breast cancer (TNBC) and is not associated with response to ipatasertib (IPAT) plus paclitaxel (PAC)

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P4-P4-10-23

2020

Volltextzugriff (PDF)

IPATunity130: A pivotal randomized phase III trial evaluating ipatasertib (IPAT) + paclitaxel (PAC) for PIK3CA/AKT1/PTEN -altered advanced triple-negative (TN) or hormone receptor-positive HER2-negative (HR+/HER2–) breast cancer (BC)

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.TPS1117-TPS1117

2018

Volltextzugriff (PDF)

Abstract CT049: Phase Ib study evaluating a triplet combination of ipatasertib (IPAT), atezolizumab (atezo), and paclitaxel (PAC) or nab-PAC as first-line (1L) therapy for locally advanced/metastatic triple-negative breast cancer (TNBC)

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.CT049-CT049

2019

Volltextzugriff (PDF)

IL-12 enhances the antitumor actions of trastuzumab via NK cell IFN-γ production

The Journal of immunology (1950), 2011-03, Vol.186 (6), p.3401-3409

2011

Volltextzugriff (PDF)

Chlorophosphonates: Inexpensive Precursors for Stereodefined Chloro-Substituted Olefins and Unsymmetrical Disubstituted Acetylenes

Journal of organic chemistry, 2000-06, Vol.65 (12), p.3733-3737

2000

Volltextzugriff (PDF)

Abstract P3-11-08: Eribulin/cyclophosphamide (ErC) versus docetaxel/cyclophosphamide (TC) as neoadjuvant therapy in locally advanced HER2-negative breast cancer: A randomized phase II trial of the Sarah Cannon Research Institute

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.P3-P3-11-08

2015

Volltextzugriff (PDF)

Impact of sequencing weekly paclitaxel (T) and dose-dense doxorubicin/cyclophosphamide (DDAC) on tolerability and relative dose intensity (RDI) in breast cancer (BC) patients (pts) receiving neoadjuvant chemotherapy (NAC)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.1048-1048

2015

Volltextzugriff (PDF)

Defining the Survival Benchmark for Breast Cancer Patients with Systemic Relapse

Breast cancer : basic and clinical research, 2015-04, Vol.2015 (9), p.9-17

2015

Volltextzugriff (PDF)

Apoptosis of multiple myeloma : Apoptosis in lymphoid neoplasia

International journal of hematology, 2004, Vol.80 (3), p.224-231

2004

Volltextzugriff (PDF)

Effect of solar activity on the minor constituents in the mesosphere and lower thermosphere

Current science (Bangalore), 1990-10, Vol.59 (20), p.988-991

1990

Volltextzugriff (PDF)

A MODEL STUDY OF EFFECT OF ELECTRON TEMPERATURE ENHANCEMENTS ON D-AND E-REGION ELECTRON DENSITIES

Current science (Bangalore), 1989, Vol.58 (21), p.1194-1195

1989

Volltextzugriff (PDF)

Effect of solar activity on the minor constituents in the mesosphere and lower thermosphere: Challenging areas in earth and atmospheric sciences

Current science (Bangalore), 1990, Vol.59 (20), p.988-991

1990

Volltextzugriff (PDF)

ChemInform Abstract: Chlorophosphonates: Inexpensive Precursors for Stereodefined Chloro-Substituted Olefins and Unsymmetrical Disubstituted Acetylenes

ChemInform, 2000-10, Vol.31 (43), p.no-no

2000

Volltextzugriff (PDF)

Effective hybrid video denoising and blending framework for Internet of Remote Things (IoRT) environments

Automatika, 2024-04, Vol.65 (2), p.510-522

2024

Volltextzugriff (PDF)

Sustainable Technical Debt-Aware Computing Model for Virtual Machine Migration (TD4VM) in IaaS Cloud

Wireless communications and mobile computing, 2022-04, Vol.2022, p.1-12

2022

Volltextzugriff (PDF)

Biomolecular characterization of Antheraea mylitta cocoonase: A secreted protease

Analytical biochemistry, 2024-03, Vol.686, p.115408-115408, Article 115408

2024

Volltextzugriff (PDF)

Visible light driven reduced graphene oxide supported ZnMgAl LTH/ZnO/g-C3N4 nanohybrid photocatalyst with notable two-dimension formation for enhanced photocatalytic activity towards organic dye degradation

Environmental research, 2021-06, Vol.197, p.111079-111079, Article 111079

2021

Volltextzugriff (PDF)

1 – 25 von 58

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)

Publikationsform

Sprache

Englisch
(58)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Phase Ib/II single-arm trial evaluating the combination of everolimus, lapatinib and capecitabine for the treatment of HER2-positive breast cancer with brain metastases (TRIO-US B-09)

Trastuzumab emtansine plus atezolizumab versus trastuzumab emtansine plus placebo in previously treated, HER2-positive advanced breast cancer (KATE2): a phase 2, multicentre, randomised, double-blind trial

Defining the Survival Benchmark for Breast Cancer Patients with Systemic Relapse

Final results of the double-blind placebo-controlled randomized phase 2 LOTUS trial of first-line ipatasertib plus paclitaxel for inoperable locally advanced/metastatic triple-negative breast cancer

Abstract PS5-06: Prospective testing for PIK3CA/AKT1/PTEN alterations in tumor tissue from 1440 patients with advanced hormone receptor-positive HER2-negative breast cancer (HR+/HER2- BC) or triple-negative breast cancer (TNBC) screened for the IPATunity130 randomized phase 3 trial

Abstract PD14-03: Molecular mechanism of ipatasertib (IPAT) and its combination with atezolizumab (atezo) in patients (pts) with locally advanced/metastatic triple-negative breast cancer (aTNBC)

Real-world (RW) characteristics, treatment (tx) patterns, and overall survival (OS) in US patients (pts) with metastatic breast cancer (mBC) and CNS metastases (CNS mets)

Abstract P4-10-23: Expression of PD-L1 is independent of PIK3CA/AKT1/PTEN alterations in triple-negative breast cancer (TNBC) and is not associated with response to ipatasertib (IPAT) plus paclitaxel (PAC)

IPATunity130: A pivotal randomized phase III trial evaluating ipatasertib (IPAT) + paclitaxel (PAC) for PIK3CA/AKT1/PTEN -altered advanced triple-negative (TN) or hormone receptor-positive HER2-negative (HR+/HER2–) breast cancer (BC)

Abstract CT049: Phase Ib study evaluating a triplet combination of ipatasertib (IPAT), atezolizumab (atezo), and paclitaxel (PAC) or nab-PAC as first-line (1L) therapy for locally advanced/metastatic triple-negative breast cancer (TNBC)

IL-12 enhances the antitumor actions of trastuzumab via NK cell IFN-γ production

Chlorophosphonates: Inexpensive Precursors for Stereodefined Chloro-Substituted Olefins and Unsymmetrical Disubstituted Acetylenes

Abstract P3-11-08: Eribulin/cyclophosphamide (ErC) versus docetaxel/cyclophosphamide (TC) as neoadjuvant therapy in locally advanced HER2-negative breast cancer: A randomized phase II trial of the Sarah Cannon Research Institute

Impact of sequencing weekly paclitaxel (T) and dose-dense doxorubicin/cyclophosphamide (DDAC) on tolerability and relative dose intensity (RDI) in breast cancer (BC) patients (pts) receiving neoadjuvant chemotherapy (NAC)

Defining the Survival Benchmark for Breast Cancer Patients with Systemic Relapse

Apoptosis of multiple myeloma : Apoptosis in lymphoid neoplasia

Effect of solar activity on the minor constituents in the mesosphere and lower thermosphere

A MODEL STUDY OF EFFECT OF ELECTRON TEMPERATURE ENHANCEMENTS ON D-AND E-REGION ELECTRON DENSITIES

Effect of solar activity on the minor constituents in the mesosphere and lower thermosphere: Challenging areas in earth and atmospheric sciences

ChemInform Abstract: Chlorophosphonates: Inexpensive Precursors for Stereodefined Chloro-Substituted Olefins and Unsymmetrical Disubstituted Acetylenes

Effective hybrid video denoising and blending framework for Internet of Remote Things (IoRT) environments

Sustainable Technical Debt-Aware Computing Model for Virtual Machine Migration (TD4VM) in IaaS Cloud

Biomolecular characterization of Antheraea mylitta cocoonase: A secreted protease

Visible light driven reduced graphene oxide supported ZnMgAl LTH/ZnO/g-C3N4 nanohybrid photocatalyst with notable two-dimension formation for enhanced photocatalytic activity towards organic dye degradation

Aktive Filter

Suchergebnisse filtern